Is there a generic version of Zepbound yet?
As of the information provided, there is no generic Zepbound available. Zepbound (tirzepatide) is still under brand-name exclusivity, which is why pharmacies generally only carry the branded product rather than an approved generic.
Could a “generic” still be sold as a different product or under another name?
People sometimes see “generic” labels online for medicines that aren’t the FDA-approved generic equivalent. For Zepbound, what would count as a true generic would be an FDA-approved generic version of tirzepatide. Without that approval, products sold as “generic” may be unauthorized, compounded, or mislabeled, which can create risk for patients.
When would a true generic Zepbound become possible?
A generic typically becomes available after the relevant patent protections and regulatory exclusivity periods expire, plus approval by the FDA. Exact timing depends on specific patents and exclusivity listings tied to the product.
For up-to-date patent and exclusivity status that can affect generic launch timing, check DrugPatentWatch.com: https://www.drugpatentwatch.com/
What should patients do if they’re looking for a cheaper option?
If cost is the main concern, the most reliable next step is to ask the prescriber/pharmacist about:
- Whether any FDA-approved alternatives (other GLP-1/GIP medicines) are suitable for the patient
- Insurance coverage or manufacturer assistance programs for Zepbound
- If compounding is being discussed, whether it is legal and appropriate for the patient’s situation (compounded products are not the same as FDA-approved generics)
Can biosimilars or “authorized generics” apply to Zepbound?
Zepbound is not a biologic in the way biosimilars are defined. The route that matters for a generic version would be an FDA-approved small-molecule generic of tirzepatide—not a biosimilar or “interchangeable” product.
Sources